Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ethereum (ETH) vs Injective (INJ) Price & Performance

Price performance (Past 24H)

Key statistics

Ethereum vs Injective — how do they compare? Ethereum trades at Rp33,726,733 (market cap Rp4.062,07T, Rp123,53T 24h volume), while Injective trades at Rp81,847 (market cap Rp8,2T, Rp802,26M 24h volume). The key difference: Ethereum is far larger — about 495.4× Injective's market cap, and Ethereum's circulating supply is 120,7M ETH versus 100M INJ for Injective. Which is the better fit depends on your goals — on Pluang, investors hold Ethereum for 104 Days and Injective for 37 Days on average.

ETHINJ
Market Cap
Rp4.062,07TRp8,2T
Volume (24h)
Rp123,53TRp802,26M
Circulating Supply
120,7M ETH100M INJ
Typical Hold Time
104 Days37 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ethereum

Ethereum is currently trading at Rp33,721,230 with a market cap of Rp4,069.13T, showing bearish technical signals with moving averages indicating selling pressure while oscillators remain neutral. The asset is trading near key support levels with RSI readings suggesting potential oversold conditions. Recent news highlights continued ecosystem development and institutional interest in Ethereum's blockchain capabilities.

Overall outlook remains cautious with bearish technical momentum but strong fundamental ecosystem growth. Key opportunities include Ethereum's dominant position in DeFi and potential from protocol upgrades, while major risks involve regulatory uncertainty and high volatility. Investors should monitor support levels and regulatory developments closely.

Injective

Injective (INJ) is currently trading at Rp81,858 with a market cap of Rp8.16 trillion. The technical outlook is bearish, with moving averages indicating selling pressure, while oscillators are neutral. Key support lies at Rp78,560. No major protocol updates or ecosystem news were identified in the latest review. Trading volume and network activity metrics are required for a complete short-term trend assessment.

Overall outlook is cautious due to bearish technical signals. The primary opportunity is a potential rebound from oversold conditions if support holds. Major risks include high volatility, lack of recent fundamental catalysts, and broader crypto market sentiment. Investors should monitor for any new ecosystem developments or shifts in trading volume.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ETH
26% Buy74% Sell
Avg holding period · 104 Days
INJ
53% Buy47% Sell
Avg holding period · 37 Days

Top news

Latest headlines on both assets

About Ethereum

A crypto asset designed for decentralized applications and deployment of smart contracts, which are created and operated without any fraud, interruption, control or interference from a third party. It is the second most valuable crypto asset after BTC.

Read more on ETH

About Injective

Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.

Read more on INJ